• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    BioTime, Inc. (BTX)

    -NYSE MKT
    3.33 Down 0.13(3.76%) Dec 19, 4:07PM EST
    Add to Portfolio
    Prev Close:3.46
    Open:3.40
    Bid:2.90 x 10000
    Ask:3.50 x 1800
    1y Target Est:8.00
    Beta:1.4
    Next Earnings Date:N/A
    Day's Range:3.33 - 3.47
    52wk Range:2.21 - 4.14
    Volume:265,596
    Avg Vol (3m):205,208
    Market Cap:227.41M
    P/E (ttm):N/A
    EPS (ttm):-0.75
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BTX

    Comparison

    Symbol% ChgMkt Cap
    BTXDown 3.76%227.41M
    BAXUp 0.55%40.37B
    HSPUp 0.35%10.60B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):44.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioTime, Inc., a biotechnology company, is engaged in the research and product development in the field of regenerative medicine. The company primarily focuses on regenerative medicine, which refers to therapies based on human embryonic stem cell ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback